Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3.47	61.17	59.12
Graham Fair Price	-3.23	34.42	35.57
PEG	414.00	-2.11	0.41
Price/Book	-2.57	4.32	4.43
Price/Cash Flow	53.88	93.88	61.01
Prices/Earnings	11.76	20.79	18.60
Price/Sales	0.49	3.05	3.03
Price/FCF	53.88	93.88	61.01
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.28	0.28	0.27
Operating Margin	-6.32	0.06	0.06
ROA	-1.61	0.01	0.01
ROE	0.06	0.05	-12.82
ROIC	0.03	0.03	-11.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	669.77
Dividends QOQ	< 0.005	< 0.005	4.26
EBIT QOQ	0.34	-0.06	-82.84
EPS QOQ	0.45	-0.10	-78.26
FCF QOQ	1.02	-0.34	-66.31
Revenue QOQ	0.02	< 0.005	-66.81
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	87.73	87.24	-0.57
Days Sales Outstanding (DSO)	1.02	0.32	-69.05
Inventory Turnover	1.03	1.03	0.57
Debt/Capitalization	0.55	0.55	-1.57
Quick Ratio	0.10	0.11	17.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	30.74	31.86	3.64
Cash	2.45	3.28	34.04
Capex	-2.09	-1.56	25.67
Free Cash Flow	2.23	1.46	-34.38
Revenue	44.90	45.12	0.49
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.19	1.22	2.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	21.87	22.36	2.22
Naive Interpretation	Member

06 - Financial Health · Weak

Rating